In wild-type mice, MG132 inhibited proteasomal activity, resulting in the significant upregulation of Nrf2 and IκB. Consequently, MG132 significantly attenuated diabetes-induced renal dysfunction, fibrosis, inflammation, and oxidative damage. This evidence concerns the gene NFE2L2 and diabetes mellitus.